Deferred Tax Assets, Valuation Allowance of LeonaBio, Inc. from 31 Dec 2019 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
LeonaBio, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2019 to 31 Dec 2024.
  • LeonaBio, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $91,949,000, a 29% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

LeonaBio, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $91,949,000 +$20,703,000 +29% 31 Dec 2024 10-K 27 Feb 2025 2024 FY
Q4 2023 $71,246,000 +$28,261,000 +66% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q4 2022 $42,985,000 +$20,418,000 +90% 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q4 2021 $22,567,000 +$13,469,000 +148% 31 Dec 2021 10-K 23 Mar 2023 2022 FY
Q4 2020 $9,098,000 +$4,308,000 +90% 31 Dec 2020 10-K 28 Mar 2022 2021 FY
Q4 2019 $4,790,000 31 Dec 2019 10-K 25 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.